Peter L. Fishman - Jan 10, 2025 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Role
SVP, CFO
Signature
/s/ Jonathan Provoost
Stock symbol
AMRN
Transactions as of
Jan 10, 2025
Transactions value $
$0
Form type
4
Date filed
1/10/2025, 05:00 PM
Previous filing
Oct 31, 2024
Next filing
Jan 31, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRN Stock Option (Right to Buy) Award $0 +440K $0.00 440K Jan 10, 2025 Ordinary Shares 440K $0.62 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant price is set at the higher of (1) our nominal par value of 50 pence per share, or as converted on date of grant of $0.62 per share, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.
F2 On January 10, 2025, the Reporting Person was granted an option to purchase 440,475 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable over eighteen months, with 50% to vest on the first anniversary of the grant date and the remaining balance to vest eighteen months after grant date.
F3 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.